Liang Yao

assistant professor

Nanyang Technological University

Singapore

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Liang Yao is an assistant professor at Nanyang Technological University in Singapore. His research areas focus on systematic reviews and meta-analyses relating to antibiotic treatments, COVID-19 drug therapies, and the GRADE approach for assessing and presenting evidence in medical guidelines. His recent publications emphasize the importance of trustworthiness in evidence ratings, the impact of treatment duration on patient outcomes, and the systematic evaluation of therapeutic interventions.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (2)

Prashanti Eachempati

University of Plymouth

UNITED KINGDOM

View details

Monica Hultcrantz

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Liang Yao

Research Interests

Contact this professor

About

Articles (10)

Core GRADE 7: principles for moving from evidence to recommendations and decisions.

Core GRADE 4: rating certainty of evidence-risk of bias, publication bias, and reasons for rating up certainty.

Core GRADE 5: rating certainty of evidence-assessing indirectness.

Core GRADE 6: presenting the evidence in summary of findings tables.

Core GRADE 1: overview of the Core GRADE approach.

Core GRADE 2: choosing the target of certainty rating and assessing imprecision.

Core GRADE 3: rating certainty of evidence-assessing inconsistency

Shorter versus longer-duration antibiotic treatments for immunocompetent patients with bloodstream infections: a systematic review and meta-analysis

Efficiency must not compromise trustworthiness in rating certainty and formulating recommendations in AI era.

Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.

Collaborators (2)

Prashanti Eachempati

Monica Hultcrantz

Make your next move.